BONADONNA, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 9.321
EU - Europa 7.858
AS - Asia 6.002
SA - Sud America 890
AF - Africa 223
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.322
Nazione #
US - Stati Uniti d'America 9.151
RU - Federazione Russa 2.874
SG - Singapore 2.693
GB - Regno Unito 1.998
CN - Cina 1.436
BR - Brasile 727
IT - Italia 651
HK - Hong Kong 556
VN - Vietnam 512
DE - Germania 446
SE - Svezia 413
FR - Francia 408
FI - Finlandia 358
IE - Irlanda 297
KR - Corea 281
UA - Ucraina 124
IN - India 79
NL - Olanda 73
CA - Canada 72
AR - Argentina 69
JP - Giappone 60
NG - Nigeria 58
MX - Messico 57
TR - Turchia 56
ID - Indonesia 52
BD - Bangladesh 50
PK - Pakistan 47
ZA - Sudafrica 43
AT - Austria 37
BJ - Benin 36
IQ - Iraq 33
BE - Belgio 29
PL - Polonia 24
UZ - Uzbekistan 23
ES - Italia 21
EC - Ecuador 20
AU - Australia 19
CO - Colombia 17
EG - Egitto 15
SA - Arabia Saudita 15
VE - Venezuela 15
GR - Grecia 13
CL - Cile 12
LT - Lituania 12
PH - Filippine 12
DZ - Algeria 11
MA - Marocco 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
JO - Giordania 10
RO - Romania 10
TN - Tunisia 10
HR - Croazia 9
MY - Malesia 9
PY - Paraguay 9
BO - Bolivia 8
ET - Etiopia 8
GH - Ghana 8
KE - Kenya 8
UY - Uruguay 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
NP - Nepal 7
AL - Albania 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
IL - Israele 6
KG - Kirghizistan 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
IR - Iran 5
OM - Oman 5
JM - Giamaica 4
KZ - Kazakistan 4
LV - Lettonia 4
NI - Nicaragua 4
PE - Perù 4
TW - Taiwan 4
BY - Bielorussia 3
BZ - Belize 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
KH - Cambogia 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PA - Panama 3
SN - Senegal 3
TG - Togo 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
Totale 24.290
Città #
Southend 1.682
Singapore 1.337
Ashburn 1.259
Jacksonville 990
Dallas 928
Moscow 917
San Jose 874
Woodbridge 742
Chandler 740
Hong Kong 550
Houston 384
Verona 357
Ann Arbor 319
Dublin 297
The Dalles 288
Beijing 218
New York 196
Ho Chi Minh City 179
Los Angeles 148
Lawrence 142
Princeton 142
Wilmington 142
Nanjing 107
Hanoi 102
Buffalo 93
Sindelfingen 82
Shenyang 81
Boardman 80
Redondo Beach 78
Helsinki 72
Munich 66
Jinan 65
São Paulo 65
London 61
Santa Clara 58
Milan 56
Abuja 52
Tokyo 50
Hebei 47
Amsterdam 45
Columbus 45
Changsha 41
Seoul 41
Tianjin 41
Cotonou 36
Nanchang 34
Nuremberg 34
Frankfurt am Main 31
Orem 31
San Francisco 31
Chicago 30
Falkenstein 30
Zhengzhou 30
Brussels 29
Turku 29
Haikou 28
Phoenix 26
Montreal 25
Rio de Janeiro 25
Brasília 24
Hangzhou 24
Redmond 24
Washington 24
Ningbo 23
Guangzhou 22
Warsaw 22
Haiphong 21
Jakarta 21
Council Bluffs 20
Johannesburg 20
Tashkent 20
Belo Horizonte 19
Toronto 19
Da Nang 18
Stockholm 18
Taiyuan 18
Vienna 18
Atlanta 17
Mianwali 17
Norwalk 17
Taizhou 17
Jiaxing 16
Baghdad 15
Bologna 15
Brooklyn 15
Curitiba 15
Dearborn 15
Dhaka 15
Mexico City 15
Shanghai 15
Lancaster 14
Romola 14
Chennai 13
Falls Church 13
Mumbai 13
Redwood City 13
Seattle 13
Hyderabad 12
Paris 12
Ankara 11
Totale 15.415
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 778
Common Variants Associated to Type 2 Diabetes in the Italian Population 491
Adipocytes IGFBP-2 expression in prepubertal obese children. 245
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 243
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 226
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 218
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 213
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 210
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 203
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 200
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 192
High-fat meal, systemic inflammation and glucose homeostasis in obese children and adolescents 192
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 190
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 190
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 190
Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 186
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 185
A compartmental model to quantitate in vivo glucose transport in the human forearm 185
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 185
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 180
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 178
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 177
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 177
Fat cell size, insulin sensitivity, and inflammation in obese children. 176
Beta-cell function across the spectrum of glucose tolerance in obese youth. 173
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 173
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 171
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 170
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 169
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 167
Metabolic and hormonal consequences of two different meals after a moderate intensity exercise bout in obese prepubertal children 166
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 166
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 164
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 163
Operation of Randle's cycle in patients with NIDDM 157
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 157
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. 156
Angiotensin converting enzyme inhibitors improve endothelial function in type I (insulin-dependent) diabetic patients with normal arterial pressure and microalbuminuria 156
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 156
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 156
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 154
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 154
Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. 153
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 153
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 152
“IGT-like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentration during the oral glucose tolerance test 152
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 151
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 150
Pathogenesis of NIDDM. A balanced overview. 148
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus 146
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 144
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 144
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 143
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 141
Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths 141
Obesity and insulin resistance in man. A dose response study 140
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 140
Effect of insulin on system A amino acid transport in human skeletal muscle 139
Estimation of blood flow heterogeneity in human skeletal muscle using intravascular tracer data: importance for modeling transcapillary exchange 136
Pleiotropic Effects of GIP on Islet Function Involve Osteopontin. 136
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 136
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus 135
In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia 133
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 131
Evaluating endothelial function of the common carotid artery: An in vivo human model. 131
Estimation of blood flow heterogeneity distribution in human skeletal muscle from positron emission tomography data 130
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 127
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 126
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 126
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 125
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. 125
Glucose metabolism in obesity and type 2 diabetes 125
Metabolic and thermogenic effects of lactate infusion in humans 124
Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose 123
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 123
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 123
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 122
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 122
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 122
Phasic insulin release and metabolic regulation in type 2 diabetes 121
Time dependence of the interaction between lipid and glucose in humans 121
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 121
Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle 120
Sintesi di glicogeno, glicolisi ed ossidazione glucidica nel paziente obeso con diabete tipo II. Contributo alla insulinoresistenza. 120
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 120
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 119
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 119
Platelet and clotting activities after cold stress in diabetic patients 117
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans 117
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 117
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 116
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 115
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 115
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 115
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 113
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 113
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man 113
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 112
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 112
Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes. 112
Totale 16.004
Categoria #
all - tutte 75.122
article - articoli 64.963
book - libri 0
conference - conferenze 9.993
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 166
Totale 150.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021244 0 0 0 0 0 0 0 0 0 35 148 61
2021/2022998 115 181 19 97 25 36 9 58 36 36 94 292
2022/20232.155 174 184 227 384 220 474 29 151 201 13 63 35
2023/20241.476 38 96 95 149 143 200 67 356 6 89 154 83
2024/20253.833 181 205 130 681 148 96 217 197 661 223 349 745
2025/202610.373 803 629 969 1.723 2.545 726 1.184 614 659 521 0 0
Totale 24.539